Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$4.2 - $6.01 $1.37 Million - $1.97 Million
327,042 New
327,042 $1.37 Billion
Q4 2022

Feb 14, 2023

BUY
$4.45 - $6.17 $1.48 Million - $2.06 Million
333,524 New
333,524 $2 Million
Q3 2022

Nov 14, 2022

SELL
$5.36 - $7.43 $661,113 - $916,431
-123,342 Reduced 24.93%
371,489 $2.16 Million
Q2 2022

Aug 15, 2022

BUY
$3.55 - $6.27 $1.14 Million - $2 Million
319,774 Added 182.67%
494,831 $2.95 Million
Q1 2022

May 11, 2022

BUY
$1.9 - $5.23 $282,577 - $777,831
148,725 Added 564.81%
175,057 $818,000
Q1 2021

May 13, 2021

SELL
$2.68 - $3.8 $7,069 - $10,024
-2,638 Reduced 9.11%
26,332 $76,000
Q4 2020

Feb 09, 2021

BUY
$2.48 - $3.8 $71,845 - $110,086
28,970 New
28,970 $93,000
Q2 2019

Aug 12, 2019

SELL
$0.8 - $1.03 $131,756 - $169,635
-164,695 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$0.9 - $1.37 $12,619 - $19,210
14,022 Added 9.31%
164,695 $159,000
Q4 2018

Feb 11, 2019

BUY
$0.73 - $2.19 $1 - $4
2 Added 0.0%
150,673 $111,000
Q2 2018

Aug 06, 2018

BUY
$3.81 - $5.26 $385,019 - $531,549
101,055 Added 203.67%
150,671 $750,000
Q1 2018

May 15, 2018

BUY
$2.7 - $4.06 $75,521 - $113,562
27,971 Added 129.23%
49,616 $193,000
Q4 2017

Feb 09, 2018

BUY
$2.47 - $3.34 $53,463 - $72,294
21,645
21,645 $58,000

About CTI BIOPHARMA CORP


  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.